Zoetis Inc. (ZTS) Position Raised by Prudential PLC

Prudential PLC boosted its position in Zoetis Inc. (NYSE:ZTS) by 4.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 149,389 shares of the company’s stock after purchasing an additional 6,811 shares during the period. Prudential PLC’s holdings in Zoetis were worth $9,319,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in ZTS. BlackRock Inc. lifted its position in Zoetis by 2,471.1% in the first quarter. BlackRock Inc. now owns 36,082,470 shares of the company’s stock valued at $1,925,722,000 after purchasing an additional 34,679,064 shares during the period. Morgan Stanley lifted its position in Zoetis by 182.5% in the first quarter. Morgan Stanley now owns 14,617,205 shares of the company’s stock valued at $780,119,000 after purchasing an additional 9,442,207 shares during the period. Marshall Wace North America L.P. acquired a new stake in Zoetis in the first quarter valued at about $243,854,000. Alliancebernstein L.P. lifted its position in Zoetis by 55.4% in the second quarter. Alliancebernstein L.P. now owns 10,370,388 shares of the company’s stock valued at $646,905,000 after purchasing an additional 3,695,449 shares during the period. Finally, Waddell & Reed Financial Inc. lifted its position in Zoetis by 65.9% in the first quarter. Waddell & Reed Financial Inc. now owns 5,434,371 shares of the company’s stock valued at $290,033,000 after purchasing an additional 2,157,803 shares during the period. Hedge funds and other institutional investors own 93.20% of the company’s stock.

Zoetis Inc. (ZTS) opened at 63.75 on Friday. Zoetis Inc. has a 52 week low of $46.86 and a 52 week high of $65.83. The stock has a market capitalization of $31.18 billion, a PE ratio of 36.04 and a beta of 1.02. The stock’s 50 day moving average is $63.41 and its 200-day moving average is $60.49.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Tuesday, August 8th. The company reported $0.53 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.53. Zoetis had a net margin of 17.50% and a return on equity of 62.49%. The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the business posted $0.49 EPS. Zoetis’s quarterly revenue was up 5.0% on a year-over-year basis. Equities research analysts forecast that Zoetis Inc. will post $2.34 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be paid a dividend of $0.105 per share. The ex-dividend date of this dividend is Wednesday, November 8th. This represents a $0.42 annualized dividend and a dividend yield of 0.66%. Zoetis’s dividend payout ratio (DPR) is 23.73%.

A number of brokerages recently commented on ZTS. BidaskClub downgraded shares of Zoetis from a “hold” rating to a “sell” rating in a research report on Friday. Cantor Fitzgerald restated a “buy” rating and issued a $75.00 price objective on shares of Zoetis in a research report on Tuesday, September 26th. Stifel Nicolaus restated a “buy” rating and issued a $65.00 price objective on shares of Zoetis in a research report on Friday, September 1st. Piper Jaffray Companies set a $73.00 price target on shares of Zoetis and gave the company a “buy” rating in a research report on Friday, August 25th. Finally, Cowen and Company set a $70.00 price target on shares of Zoetis and gave the company a “buy” rating in a research report on Thursday, August 24th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $65.44.

COPYRIGHT VIOLATION WARNING: “Zoetis Inc. (ZTS) Position Raised by Prudential PLC” was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://transcriptdaily.com/2017/10/08/zoetis-inc-zts-position-raised-by-prudential-plc.html.

About Zoetis

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply